A clinical trial of ALS patients conducted by BrainStorm Cell Therapeutics shows its adult stem cell therapy is well-tolerated, appears to be safe and does not present undue risk, according to an interim safety review.
Papildomos nuorodos
Israel adult stem cell trials – hope for ALS patients?
Šis įrašas paskelbtas Kamieninių ląstelių tyrimai kategorijose.
